Developer docs
API playgroundTry for free, no card

Search company profiles

True Positive Medical Devices

Full company profile

uuid000ipm8

Namestring
True Positive Medical Devices
Company typeenum
Private
Founded yearint
2011
Descriptiontext

True Positive MD develops imaging software analytics to assess brain health.

Short descriptiontext

True Positive MD develops imaging software analytics to assess brain health.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersQuebec, Canada
HQ citystring
Quebec
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
brain health imaging, neuroimaging software, medical imaging analytics, brain assessment software, neurological imaging diagnostics
Industry1 code
1Medical Imaging AI
CodeHDAAAEAHPrimaryYes
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Medical Imaging Analytics Software
Social media profiles1 record
Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

True Positive MD develops imaging software analytics to assess brain health. The company builds a software-based analytics product that processes medical imaging data to support neurological assessment and brain health evaluation for healthcare and clinical research users.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Imaging Software Analytics for Brain Health
CategoryMedical Imaging Analytics Software
Description

Software-based analytics tool that processes medical imaging data to assess brain health, intended for healthcare providers, neurologists, and clinical research users who need quantitative brain health assessment from imaging.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
1icometrix
TypeDirect peer
Description

icometrix develops AI-based software for brain MRI analysis focused on neurological disorders such as MS, dementia, and TBI. It is the most direct comparable to True Positive MD given the shared brain-health imaging analytics focus and clinical/research customer base.

2BrainSpec
TypeDirect peer
Description

BrainSpec offers MR spectroscopy-based software to quantify brain metabolites for neurological and psychiatric assessment. It directly competes in the brain-imaging analytics category, addressing similar clinical decision-support use cases.

3Qubiotech
TypeDirect peer
Description

Qubiotech provides AI-enhanced brain PET and MRI quantification tools for neurodegenerative disease and oncology. Comparable to True Positive MD in both modality (brain imaging) and customer type (clinical/research nuclear medicine and neurology).

4Viz.ai
TypeEmerging player
Description

Viz.ai applies AI to neuroimaging for time-sensitive conditions such as stroke and intracranial hemorrhage. While its acute-care focus differs from True Positive MD's broader brain-health analytics framing, both target radiology workflows with imaging AI.

5RapidAI
TypeEmerging player
Description

RapidAI develops AI-driven neuroimaging analysis platforms for stroke and other cerebrovascular conditions. Overlaps with True Positive MD in brain imaging analytics but is more focused on acute stroke workflows.

6Aidoc
TypeBroad incumbent
Description

Aidoc offers a broad radiology AI platform covering multiple body parts and pathologies, including brain imaging (e.g., intracranial hemorrhage triage). It is a broader incumbent whose neurology footprint overlaps with True Positive MD's brain-health focus.

7Quibim
TypeEmerging player
Description

Quibim provides AI-powered medical imaging biomarkers across multiple anatomies, including brain imaging for neurodegenerative and oncologic conditions. Comparable technology stack and biomarker-driven approach to True Positive MD.

8Arterys (Tempus AI)
TypeBroad incumbent
Description

Arterys, now part of Tempus AI, delivers cloud-based medical imaging AI for cardiac, lung, and brain imaging. Overlaps with True Positive MD in brain imaging analytics within a broader multi-organ AI platform.

9Blackford Analysis
TypeEmerging player
Description

Blackford Analysis curates and distributes a marketplace of radiology AI applications, including brain imaging tools. Comparable as an enabler of third-party neuroimaging AI deployment, though its business model emphasizes platform aggregation rather than proprietary analytics.

10MedQIA
TypeEmerging player
Description

MedQIA provides quantitative imaging analysis services and software for clinical trials and research, including brain imaging endpoints. Comparable to True Positive MD in serving clinical research and pharma trial imaging biomarker needs.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

True Positive Medical Devices

Medical Imaging Analytics Softwaretruepositivemd.com

True Positive MD develops imaging software analytics to assess brain health.

What True Positive Medical Devices does

True Positive MD develops imaging software analytics to assess brain health.

True Positive Medical Devices firmographics

Firmographics
Name
True Positive Medical Devices
Website
http://truepositivemd.com/
Company type
Private
Founded year
2011
Headcount range
1–10 employees
Short description
True Positive MD develops imaging software analytics to assess brain health.
Ownership category
akta.pro rank

True Positive Medical Devices industry classification

Industry
Product category
Medical Imaging Analytics Software
NAICS
Software Publishers (5132)
SIC
Services-Prepackaged Software (7372)
akta.pro primary industry
Medical Imaging AI (HDAAAEAH)

Keywords

  • Brain health imaging
  • Neuroimaging software
  • Medical imaging analytics
  • Brain assessment software
  • Neurological imaging diagnostics

Where True Positive Medical Devices is headquartered

Location

Headquarters

HQ city
Quebec
HQ country
Canada
HQ region
North America

Markets served

True Positive Medical Devices business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

True Positive Medical Devices product offering

Product offering

Core offering

True Positive MD develops imaging software analytics to assess brain health. The company builds a software-based analytics product that processes medical imaging data to support neurological assessment and brain health evaluation for healthcare and clinical research users.

Differentiator

Problem solved

Functional benefit

Products and services

  • Imaging Software Analytics for Brain Health Software-based analytics tool that processes medical imaging data to assess brain health, intended for healthcare providers, neurologists, and clinical research users who need quantitative brain health assessment from imaging.

Companies that use True Positive Medical Devices

Customer profile

Ideal customer profiles1 record

True Positive Medical Devices technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

True Positive Medical Devices partnerships and signals

Strategic signal

Recent moves1 record

Expansion highlights1 record

True Positive Medical Devices competitors and assessment

Company assessment

Direct peers

  • icometrix: icometrix develops AI-based software for brain MRI analysis focused on neurological disorders such as MS, dementia, and TBI. It is the most direct comparable to True Positive MD given the shared brain-health imaging analytics focus and clinical/research customer base.
  • BrainSpec: BrainSpec offers MR spectroscopy-based software to quantify brain metabolites for neurological and psychiatric assessment. It directly competes in the brain-imaging analytics category, addressing similar clinical decision-support use cases.
  • Qubiotech: Qubiotech provides AI-enhanced brain PET and MRI quantification tools for neurodegenerative disease and oncology. Comparable to True Positive MD in both modality (brain imaging) and customer type (clinical/research nuclear medicine and neurology).

Emerging players

  • Viz.ai: Viz.ai applies AI to neuroimaging for time-sensitive conditions such as stroke and intracranial hemorrhage. While its acute-care focus differs from True Positive MD's broader brain-health analytics framing, both target radiology workflows with imaging AI.
  • RapidAI: RapidAI develops AI-driven neuroimaging analysis platforms for stroke and other cerebrovascular conditions. Overlaps with True Positive MD in brain imaging analytics but is more focused on acute stroke workflows.
  • Quibim: Quibim provides AI-powered medical imaging biomarkers across multiple anatomies, including brain imaging for neurodegenerative and oncologic conditions. Comparable technology stack and biomarker-driven approach to True Positive MD.
  • Blackford Analysis: Blackford Analysis curates and distributes a marketplace of radiology AI applications, including brain imaging tools. Comparable as an enabler of third-party neuroimaging AI deployment, though its business model emphasizes platform aggregation rather than proprietary analytics.
  • MedQIA: MedQIA provides quantitative imaging analysis services and software for clinical trials and research, including brain imaging endpoints. Comparable to True Positive MD in serving clinical research and pharma trial imaging biomarker needs.

Broad incumbents

  • Aidoc: Aidoc offers a broad radiology AI platform covering multiple body parts and pathologies, including brain imaging (e.g., intracranial hemorrhage triage). It is a broader incumbent whose neurology footprint overlaps with True Positive MD's brain-health focus.
  • Arterys (Tempus AI): Arterys, now part of Tempus AI, delivers cloud-based medical imaging AI for cardiac, lung, and brain imaging. Overlaps with True Positive MD in brain imaging analytics within a broader multi-organ AI platform.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

True Positive Medical Devices social profiles

Digital presence

True Positive Medical Devices financial estimates

Financial estimate

Revenue estimate

Valuation estimate

True Positive Medical Devices leadership team

Management profile

Number of profiles

True Positive Medical Devices funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

True Positive Medical Devices M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about True Positive Medical Devices

What does True Positive Medical Devices do?

True Positive MD develops imaging software analytics to assess brain health. The company builds a software-based analytics product that processes medical imaging data to support neurological assessment and brain health evaluation for healthcare and clinical research users.

When was True Positive Medical Devices founded?

True Positive Medical Devices was founded in 2011. It employs 1 to 10 people.

Where is True Positive Medical Devices based?

True Positive Medical Devices is headquartered in Quebec, Canada, in the North America region.

Who are True Positive Medical Devices's main competitors?

Direct peers on record are icometrix, BrainSpec and Qubiotech. Emerging players are Viz.ai, RapidAI, Quibim, Blackford Analysis and MedQIA. Broad incumbents are Aidoc and Arterys (Tempus AI).

Does True Positive Medical Devices have an API?

No public API is recorded for True Positive Medical Devices.

What industry is True Positive Medical Devices in?

True Positive Medical Devices's product category is Medical Imaging Analytics Software. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI. Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireQYNAPSE to sponsor and exhibit at the 106th RSNA Annual Meeting and present its latest AI-neuroimaging advancements, which are transforming care for patients with brain disordersQYNAPSE Inc. announced it will sponsor and exhibit at the 106th RSNA Annual Meeting, presenting its FDA-cleared QyScore® medical device for automated quantification of neuroimaging markers in neurodegenerative and neuroinflammatory disorders. The company also highlighted recent strategic moves including the acquisition of TRUE POSITIVE MEDICAL DEVICES Inc. and collaborations with McGill and Laval Universities in Canada. QYNAPSE's AI platform supports diagnosis and monitoring of conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis, with operations spanning France, the United States, and Canada.PR NewswireQYNAPSE (Frankreich) und TRUE POSITIVE MEDICAL DEVICES (Kanada) gehen für die Bereitstellung der fortschrittlichsten KI-Plattform für Gehirnerkrankungen eine Partnerschaft einFrench medtech company QYNAPSE SAS announced the acquisition of Canadian company TRUE POSITIVE MEDICAL DEVICES Inc (TPMD), a spin-off from McGill University and Université Laval, on October 13, 2020. The deal encompasses 15 patents, including 9 granted in the US and Canada, combining TPMD's brain imaging AI technologies with QYNAPSE's existing QyScore® platform to create an advanced AI solution for neurological diseases such as Alzheimer's, Parkinson's, multiple sclerosis, stroke, and epilepsy. TPMD will be integrated into QYNAPSE CANADA Inc., and its founders will join QYNAPSE's scientific advisory board.PR NewswireQYNAPSE (France) and TRUE POSITIVE MEDICAL DEVICES (Canada) are partnering to provide the most advanced AI platform for brain diseasesFrench medical technology company QYNAPSE SAS has acquired Canadian company TRUE POSITIVE MEDICAL DEVICES Inc. (TPMD), a spin-off from McGill University and Université Laval, in a strategic collaboration combining TPMD's brain imaging AI technologies and 15 patents with Qynapse's existing product line. The acquisition creates what the companies claim will be the most advanced AI platform for imaging brain diseases such as Alzheimer's, Parkinson's, and multiple sclerosis. TPMD founders will join QYNAPSE's scientific board, and TPMD will be integrated into a newly formed entity, QYNAPSE CANADA Inc., with operations spanning Paris, Boston, Montreal, and Quebec City.